The United States Non-Invasive Prenatal Testing market is anticipated to grow over US$ 2.2 Billion by 2027. The growth in the U.S. Non-Invasive Prenatal Testing (NIPT) market is largely attributed to factors such as the high risk of chromosomal abnormalities with increasing maternal age, increase in incidences of chromosomal aneuploidies among fetus, development of advanced […]